{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:31:14Z","timestamp":1792812674593,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA003574"],"award-info":[{"award-number":["R01DA003574"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0178-6","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T12:58:06Z","timestamp":1501073886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Harm reduction in the USA: the research perspective and an archive to David Purchase"],"prefix":"10.1186","volume":"14","author":[{"given":"Don C.","family":"Des Jarlais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"178_CR1","first-page":"382","volume-title":"Harm reduction in substance use and high-risk behaviour","author":"CA Moore","year":"2012","unstructured":"Moore CA. History and context of harm reduction in the united states. In: Richard Pates DR, editor. Harm reduction in substance use and high-risk behaviour. United States: John Wiley & Sons; 2012. p. 382\u201394."},{"key":"178_CR2","first-page":"127","volume-title":"Alcohol and public policy: beyond the shadow of prohibition","author":"P Aaron","year":"1981","unstructured":"Aaron P, Musto D. Temperance and prohibition in America: a historical overview. In: Alcohol and public policy: beyond the shadow of prohibition; 1981. p. 127\u201381."},{"key":"178_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1360-0443.1984.tb03845.x","volume":"79","author":"HG Levine","year":"1984","unstructured":"Levine HG. The alcohol problem in America: from temperance to alcoholism. Addiction. 1984;79:109\u201319.","journal-title":"Addiction"},{"key":"178_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14664650008567016","volume":"1","author":"DL Ahmad","year":"2000","unstructured":"Ahmad DL. Opium smoking, anti-Chinese attitudes, and the American medical community, 1850\u20131890. Am Nineteenth Century Hist. 2000;1:53\u201368.","journal-title":"Am Nineteenth Century Hist"},{"key":"178_CR5","unstructured":"Davis DR, University MS. African Americans and cocaine: a historiography. Birmingham: Michigan State University; 2008."},{"key":"178_CR6","unstructured":"Gonzalez G, Tienda M. The drug connection in U. S.-Mexican relations. San Diego: DIANE Publishing Company; 1996."},{"key":"178_CR7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jama.1989.03420070058030","volume":"261","author":"DC Des Jarlais","year":"1989","unstructured":"Des Jarlais DC, Friedman SR, Novick DM, Sotheran JL, Thomas P, Yancovitz S, Mildvan D, Weber J, Kreek MJ, Maslansky R, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261:1008\u201312.","journal-title":"JAMA"},{"key":"178_CR8","volume-title":"Addicts who survived: an oral history of narcotic use in America 1923\u20131965","author":"D Courtwright","year":"1989","unstructured":"Courtwright D, Joseph H, Des Jarlais DC. Addicts who survived: an oral history of narcotic use in America 1923\u20131965. Knoxville: University of Tennessee Press; 1989."},{"key":"178_CR9","volume-title":"MMWR Weekly Report","author":"Centers for Disease Control and Prevention","year":"1981","unstructured":"Centers for Disease Control and Prevention. First Report of AIDS. In: CDC, editor. MMWR Weekly Report, vol. 50. Atlanta: Centers for Disease Control; 1981."},{"key":"178_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/QAD.0000000000001039","volume":"30","author":"DC Des Jarlais","year":"2016","unstructured":"Des Jarlais DC, Kerr T, Carrieri P, Feelemyer J, Arasteh K. HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS. 2016;30:815\u201326.","journal-title":"AIDS"},{"key":"178_CR11","unstructured":"Des Jarlais DC, Feelemyer J, Modi S, Arasteh A, Mathers B, Degenhardt L, Hagan H. Patterns in transitions from injection drug use to heterosexual HIV\/AIDS epidemics. In: The lancet special series on HIV in people who use drugs; December 10 & 11. Kuala Lampur; 2010."},{"key":"178_CR12","doi-asserted-by":"crossref","unstructured":"Kleiman MAR, Hawdon JE. Encyclopedia of drug policy. Thousand Oaks: SAGE Publications; 2011.","DOI":"10.4135\/9781412976961"},{"key":"178_CR13","doi-asserted-by":"crossref","unstructured":"Reinarman C, Levine HG. Crack in America: demon drugs and social justice. Berkeley: University of California Press; 1997.","DOI":"10.1525\/9780520916913"},{"key":"178_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00146260","volume":"9","author":"E Van Ameijden","year":"1993","unstructured":"Van Ameijden E, Van den Hoek J, Mientjes G, Coutinho R. A longitudinal study on the Incidence and transmission patterns of HIV, HBV and HCV infections among IDUs in Amsterdam. Eur J Epidemiol. 1993;9:255\u201362.","journal-title":"Eur J Epidemiol"},{"key":"178_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2105\/AJPH.81.11.1506","volume":"81","author":"W Anderson","year":"1991","unstructured":"Anderson W. The New York needle trial: the politics of public health in the age of AIDS. Am J Public Health. 1991;81:1506\u201317.","journal-title":"Am J Public Health"},{"key":"178_CR16","first-page":"1","volume":"2","author":"SC Joseph","year":"1989","unstructured":"Joseph SC, Des Jarlais DC. Needle and syringe exchange as a method of AIDS Epidemic Control. AIDS Updates. 1989;2:1\u20138.","journal-title":"AIDS Updates"},{"key":"178_CR17","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/j.1360-0443.1993.tb02044.x","volume":"88","author":"H Hagan","year":"1993","unstructured":"Hagan H, Des Jarlais DC, Purchase D, Friedman SR, Reid TR, Bell TA. An interview study of participants in the Tacoma, Washington, syringe exchange. Addiction. 1993;88:1691\u20137.","journal-title":"Addiction"},{"key":"178_CR18","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2105\/AJPH.85.11.1531","volume":"85","author":"H Hagan","year":"1995","unstructured":"Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995;85:1531\u20137.","journal-title":"Am J Public Health"},{"key":"178_CR19","unstructured":"Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Reid T. Multiple outcome measures of the impact of the Tacoma syringe exchange. In: 8th International Conference on AIDS. Amsterdam; 1992."},{"key":"178_CR20","doi-asserted-by":"crossref","unstructured":"Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven\u2019s needle exchange program: client shift or needle exchange? Am J Public Health. 1994;84:1991-4.","DOI":"10.2105\/AJPH.84.12.1991"},{"key":"178_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(96)02536-6","volume":"348","author":"DC Des Jarlais","year":"1996","unstructured":"Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Jose B, Friedman SR. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987\u201391.","journal-title":"Lancet"},{"key":"178_CR22","first-page":"652","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention. Update: syringe exchange programs\u2014United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:652.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"178_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013. MMWR Morbid Mortal Wkly Rep. 2015;64:1337\u201341.","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"178_CR24","first-page":"1488","volume":"59","author":"V Guardino","year":"2010","unstructured":"Guardino V, Des Jarlais D, Arasteh K, Johnston R, Purchase D, Solberg A. Syringe exchange programs\u2014United States, 2008. MMWR Morbid Mortal Wkly Rep. 2010;59:1488\u201391.","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"178_CR25","unstructured":"PubMed search results: syringe exchange in the United States. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=(syringe+exchange)+AND+(United+States) . Accessed 24 Mar 2017."},{"key":"178_CR26","volume-title":"The twin epidemics of substance use and HIV","author":"National Commission on Acquired Immune Deficiency Syndrome","year":"1991","unstructured":"National Commission on Acquired Immune Deficiency Syndrome. In: National Commission on AIDS, editor. The twin epidemics of substance use and HIV. Washsington DC: National Commission on Acquired Immune Deficiency Syndrome; 1991."},{"key":"178_CR27","volume-title":"A National Strategy for Prevention and Control of Hepatitis B and C","author":"Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practices","year":"2010","unstructured":"Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practices. In: Colvin H, Mitchell A, editors. A National Strategy for Prevention and Control of Hepatitis B and C. Washington: Institute of Medicine of the National Academies; 2010."},{"key":"178_CR28","volume-title":"A National Strategy for Prevention and Control of Hepatitis B and C: Phase II","author":"Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practices","year":"2017","unstructured":"Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practices. In: Colvin H, Mitchell A, editors. A National Strategy for Prevention and Control of Hepatitis B and C: Phase II. Washington: Institute of Medicine of the National Academies; 2017."},{"key":"178_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.drugpo.2015.04.008","volume":"26","author":"ST Allen","year":"2015","unstructured":"Allen ST, Ruiz MS, O\u2019Rourke A. The evidence does not speak for itself: the role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities. Int J Drug Policy. 2015;26:688\u201395.","journal-title":"Int J Drug Policy"},{"key":"178_CR30","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/00002030-200006001-00003","volume":"14","author":"K Blankenship","year":"2000","unstructured":"Blankenship K, Bray S, Merson M. Structural interventions in public health. AIDS. 2000;14:S11\u201321.","journal-title":"AIDS"},{"key":"178_CR31","first-page":"59","volume":"83","author":"K Blankenship","year":"2006","unstructured":"Blankenship K, Friedman S, Dworkin S, Mantell J. Structural interventions: concepts, challenges and opportunities for research. JUrban Health. 2006;83:59\u201372.","journal-title":"JUrban Health"},{"key":"178_CR32","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1360-0443.2008.02465.x","volume":"104","author":"DC Des Jarlais","year":"2009","unstructured":"Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104:1441.","journal-title":"Addiction"},{"key":"178_CR33","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti L, Helm S, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician. 2012;15:ES9\u201338.","journal-title":"Pain Physician"},{"key":"178_CR34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.emc.2015.11.002","volume":"34","author":"RG Wilkerson","year":"2016","unstructured":"Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The opioid epidemic in the United States. Emerg Med Clin North Am. 2016;34:e1\u2013e23.","journal-title":"Emerg Med Clin North Am"},{"key":"178_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154\u201363.","journal-title":"N Engl J Med"},{"key":"178_CR36","volume-title":"Overdose death rates United States","author":"National Institutes on Drug Abuse","year":"2017","unstructured":"National Institutes on Drug Abuse. In: NIDA, editor. Overdose death rates United States. Washington DC: NIDA; 2017."},{"key":"178_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM. HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375:229\u201339.","journal-title":"N Engl J Med"},{"key":"178_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jama.2015.6303","volume":"314","author":"JD Rich","year":"2015","unstructured":"Rich JD, Adashi EY. Ideological anachronism involving needle and syringe exchange programs: lessons from the Indiana HIV outbreak. JAMA. 2015;314:23\u20134.","journal-title":"JAMA"},{"key":"178_CR39","doi-asserted-by":"publisher","unstructured":"Dawson L, Strathdee SA, London AJ, et al. Addressing ethical challenges in HIV prevention research with people who inject drugs. J Med Ethics. 2016. doi: 10.1136\/medethics-2015-102895 .","DOI":"10.1136\/medethics-2015-102895"},{"key":"178_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10461-013-0664-0","volume":"18","author":"DC Des Jarlais","year":"2014","unstructured":"Des Jarlais DC, Arasteh K, McKnight C, Feelemyer J, Hagan H, Cooper HL, Perlman D. Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City. AIDS Beh. 2014;18:443\u201351.","journal-title":"AIDS Beh"},{"key":"178_CR41","volume-title":"Report on ethical and policy issues in research involving human participants","author":"National Bioethics Advisory Comission","year":"2016","unstructured":"National Bioethics Advisory Comission. Research Involving Human Participants. In: National Bioethics Advisory Comission, editor. Report on ethical and policy issues in research involving human participants. United States: National Bioethics Advisory Commission; 2016."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-017-0178-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T20:06:48Z","timestamp":1719346008000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0178-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0178-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"assertion":[{"value":"21 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable: there were no human subjects involved in this commentary.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}